CH50 and free eculizumab levels after in vitro addition of eculizumab to plasma from 2 healthy individuals and 2 untreated PNH patients. CH50 (•) and free eculizumab levels (♦) are shown for each time point. (A-B) Healthy controls. (C-D) Hemolytic PNH patients not receiving eculizumab.